CS logo
small CS logo
University of North Texas Health Science Center

Fort Worth, Texas, United States
Medical school in Fort Worth, Texas
3500 Camp Bowie Blvd, Fort Worth, TX 76107

About University of North Texas Health Science Center


The University of North Texas Health Science Center is a public academic health science center in Fort Worth, Texas. It is part of the University of North Texas System and was founded in 1970 as the Texas College of Osteopathic Medicine.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Centers for Disease Control and Prevention
17
University of North Texas Health Science Center
16
Pfizer
5
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
3
Boehringer Ingelheim
2
Healthpoint
2
University of Minnesota
2
Accentia Biopharmaceuticals
1
Alzheimer's Disease Cooperative Study (ADCS)
1
Anne E Ray
1
Boston Scientific Corporation
1
Total Rows: 25

Clinical Trials at University of North Texas Health Science Center


During the past decade, University of North Texas Health Science Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 14 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years224455333311111122112211332200221122Started TrialsCompleted Trails2015201620172018201920202021202220230246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Eflornithine in Treating Patients With Bladder Cancer
1999-02-01
2007-05-01
Completed
450
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
1995-04-01
2001-03-01
Completed
1,000
TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB
1999-07-01
2002-11-01
Completed
150
TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
1999-02-01
2003-02-01
Completed
215
TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
2000-08-01
2010-12-01
Completed
98
TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine
2000-03-01
2001-05-01
Completed
36
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
2000-02-01
2002-02-01
Completed
20
TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz
1999-11-01
2004-02-01
Completed
20

Rows per page:

1–65 of 65

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of North Texas Health Science Center" #1 sponsor was "Centers for Disease Control and Prevention" with 17 trials, followed by "University of North Texas Health Science Center" with 16 trials sponsored, "Pfizer" with 5 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Texas Health Science Center" #1 collaborator was "US Department of Veterans Affairs" with 11 trials as a collaborator, "American Osteopathic Association" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 54 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCenters for DiseaseControl and Prevention:17Centers for DiseaseControl and Prevention:17University of NorthTexas Health ScienceCenter: 16University of NorthTexas Health ScienceCenter: 16Pfizer: 5Pfizer: 5JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3Boehringer Ingelheim: 2Boehringer Ingelheim: 2Healthpoint: 2Healthpoint: 2University of Minnesota: 2University of Minnesota: 2Accentia Biopharmaceuticals: 1Accentia Biopharmaceuticals: 1Alzheimer's DiseaseCooperative Study(ADCS): 1Alzheimer's DiseaseCooperative Study(ADCS): 1Anne E Ray: 1Anne E Ray: 1

Created with Highcharts 11.1.0Top CollaboratorsUS Department ofVeterans Affairs: 11US Department ofVeterans Affairs: 11American OsteopathicAssociation: 4American OsteopathicAssociation: 4National Institute onAging (NIA): 3National Institute onAging (NIA): 3National Institute onAlcohol Abuse andAlcoholism (NIAAA): 3National Institute onAlcohol Abuse andAlcoholism (NIAAA): 3Pfizer: 3Pfizer: 3Alzheimer's ClinicalTrials Consortium: 2Alzheimer's ClinicalTrials Consortium: 2Bayer: 2Bayer: 2Brigham and Women'sHospital: 2Brigham and Women'sHospital: 2Eli Lilly and Company: 2Eli Lilly and Company: 2National Heart, Lung,and Blood Institute(NHLBI): 2National Heart, Lung,and Blood Institute(NHLBI): 2

Clinical Trials Conditions at University of North Texas Health Science Center


According to Clinical.Site data, the most researched conditions in "University of North Texas Health Science Center" are "Tuberculosis" (13 trials), "Alzheimer's Disease" (6 trials), "HIV Infections" (5 trials), "Chronic Low Back Pain" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "University of North Texas Health Science Center" in a lesser frequency.

Clinical Trials Intervention Types at University of North Texas Health Science Center


Most popular intervention types in "University of North Texas Health Science Center" are "Drug" (37 trials), "Other" (10 trials), "Behavioral" (7 trials), "Biological" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Isoniazid" (4 trials), "Rifabutin" (4 trials), "Bapineuzumab 0.5 mg/kg" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

Clinical Trials Genders at University of North Texas Health Science Center


The vast majority of trials in "University of North Texas Health Science Center" are 63 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at University of North Texas Health Science Center


Currently, there are 9 active trials in "University of North Texas Health Science Center". 3 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in University of North Texas Health Science Center, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in University of North Texas Health Science Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 20 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 22Phase 3: 22Not Applicable: 20Not Applicable: 20Phase 2: 10Phase 2: 10Phase 4: 5Phase 4: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 49Completed: 49Recruiting: 4Recruiting: 4Terminated: 4Terminated: 4Not yet recruiting: 3Not yet recruiting: 3Withdrawn: 2Withdrawn: 2Active, not recruiting: 1Active, not recruiting: 1Enrolling by invitation: 1Enrolling by invitation: 1Unknown status: 1Unknown status: 1